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Abstract
Background: Recent studies suggest that a Mediterranean dietary pattern during pregnancy may influence preg-
nancy outcomes. The aim of this study was to evaluate the effect of adherence to a Mediterranean diet (MD)
during pregnancy on fetal growth restriction (FGR) and preterm delivery (PTD) in a French Caribbean island
where the population is largely of African descent and presents dietary patterns similar to MD.
Methods: Using data from the TIMOUN Mother–Child Cohort Study conducted in Guadeloupe (French West
Indies) between 2004 and 2007, we analysed data for 728 pregnant women who delivered liveborn singletons
without any major congenital malformations. Degree of adherence to MD during pregnancy was evaluated with a
semi-quantitative food frequency questionnaire based on nine dietary criteria. Multiple logistic regression models
were used to analyse birth outcomes while taking potential confounders into account.
Results: Overall there was no association between MD adherence during pregnancy and the risk of PTD or FGR.
However, pre-pregnancy body mass index was a strong effect modifier, and MD adherence was associated with a
decreased risk of PTD specifically in overweight and obese women (adjusted odds ratio 0.7, 95% confidence
interval 0.6, 0.9) (P heterogeneity <0.01).
Conclusions: These results suggest that Caribbean diet during pregnancy may carry some benefits of MD and may
contribute to reduce the risk of PTD in overweight and obese pregnant women.
Keywords: Mediterranean diet, preterm birth, fetal development, French West Indies.
Dietary patterns during pregnancy may have a consid-
erable influence on fetal growth and the future health
of children. Since the early 1990s, several studies have
shown the beneficial role of some specific food groups
(such as fish, fruits, vegetables and dairy products)
and nutrients (such as omega-3 fatty acids, vitamins
and minerals) on pregnancy and infant health-related
outcomes.1–4 Some other food categories such as pro-
cessed meat and sweet drinks5 were shown to have a
detrimental role. Such studies usually did not con-
sider the maternal diet as a whole and ignored the
existing food and nutrient interactions that define the
global diet of the women.6 This limitation has been
addressed using factor analysis to identify dietary pat-
terns empirically derived from the observed con-
sumptions within the population under study or
based on a priori hypotheses (referring to dietary rec-
ommendations or adherence to presumably beneficial
dietary patterns).
Recently, several mother–child cohorts have exam-
ined the potential benefits of adherence to a tradi-
tional Mediterranean dietary pattern (characterised by
a high monounsaturated/saturated fat ratio, moderate
consumption of milk and dairy products and of
ethanol, high consumption of vegetables, fruits,
legumes and grains, and low consumption of meat
and meat products)7,8 during pregnancy on pregnancy
outcomes and child development. Adherence to a
Mediterranean diet (MD) during pregnancy was
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associated with reduced risk of preterm delivery
(PTD) in Denmark9 but not in Norway,10 and of spina
bifida malformations.11 Low adherence to an MD in
early pregnancy was associated with decreased intrau-
terine size with a lower placental and birthweight,12
while high adherence might modify the detrimental
effect of smoking on birth size.13 A reduction in the
risk of asthma and atopy in childhood has been
observed in association with high level of adherence
to MD during pregnancy in Spain but not in a cross-
sectional study in Mexico.14
Until now, most investigations of the impact of the
MD in pregnant women have studied Northern Euro-
pean (such as Danish and Norwegian) and Mediterra-
nean populations (Spanish and Greek). Our study
focuses on the population of the French West Indies,
where most of the population is of African descent,
and where rates of PTD and low birthweight are high
compared with the French mainland.15 Dietary pat-
terns observed in this population have several charac-
teristics of an MD, including high intakes of fruits,
vegetables, fish and crustaceans, and low intakes of
cheese and sweets.
The objective of this study was to evaluate
the impact of MD adherence during pregnancy
on fetal growth restriction (FGR) and PTD in a
large population-based mother–child cohort study
(TIMOUN) set up in Guadeloupe in 2004.
Methods
Population and study design
The study population consisted of pregnant women
enrolled in the Guadeloupean prospective mother–
child cohort study TIMOUN, from November 2004 to
December 2007. Women who had been living in Gua-
deloupe for at least 3 years were invited to participate
in the study during the third-trimester prenatal visit at
a Guadeloupe public hospital (university and local
hospital) or a local antenatal care clinic. Doctors pre-
sented the objectives of the study, and each participant
provided written informed consent. At inclusion,
women responded to a detailed questionnaire about
their sociodemographic characteristics, medical and
obstetric history, occupation and life style during
in-person interviews, and specially trained midwives
collected medical data. Data collected at delivery
included the newborn’s health status and details of
delivery. A food frequency questionnaire (FFQ),
asking about usual dietary intake during this preg-
nancy, was also administered shortly after delivery.
From 2004 to 2007, the study included 1068 women,
820 (77%) of whom completed the FFQ. Twenty-three
women were further excluded from the analysis
because the FFQ or outcome information was incom-
plete, and 25 were excluded for implausible values for
total energy intake (outside the range of 3347–
25 104 kJ/d). Finally, the analysis was restricted to
women with a liveborn singleton pregnancy without
major congenital malformations. The final analysis
was based on 728 pregnant women. All procedures
were approved by the Guadeloupean Advisory Com-
mittee on the Protection of Persons in Biomedical
Research.
Dietary assessment
Women were interviewed about their diet during the
current pregnancy with a validated semi-quantitative
FFQ including 214 food items administered by trained
interviewers in the days following delivery. For each
food item, women declared their usual frequency and
portion size of intake from which we estimated a daily
intake (g/day) by multiplying the intake frequency by
the portion size (details of the construction of the
questionnaire are given in Supporting Information
File S1).
The validity and reproducibility of the FFQ were
evaluated by several methods (Supporting Informa-
tion File S1). The FFQ-based method showed a good
reproducibility and validity when compared with a
diary-based method in a validation sample (73.0% of
total energy intakes classified in the same or adjacent
quintile by both methods). Correlations between fatty
acid intake estimates from FFQ and maternal blood
concentrations of fatty acids were on the order of
those previously reported in the literature.
To evaluate the degree of adherence to the tradi-
tional MD during pregnancy, we used a scale con-
structed by Trichopoulou et al.16 revised to include fish
intake.17 Each of the 214 items was classified among
the nine categories of the Mediterranean scale (vegeta-
bles, legumes, fruits and nuts, cereals, fish, meat and
poultry, dairy products, alcohol and fat). As done pre-
viously in studies among pregnant women,13 the
classification of food groups as beneficial or detrimen-
tal differed from the traditional MD in the general
population: we presumed dairy products to be ‘pro-
tective’ components4 and alcohol consumption to be
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‘detrimental’.18 For beneficial components (vegetables,
legumes, fruits and nuts, cereals, fish and dairy prod-
ucts), women with daily intake (g/day) below the
(cohort-specific) median were assigned a value of 0,
and women with consumption at or above the median
were assigned a value of 1. For components presum-
ably detrimental (meat, poultry and alcohol), women
with daily intake below the median were assigned a
value of 1, and women with intake at or above the
median were assigned a value of 0. The fat compo-
nents were expressed as the ratio of monounsaturated
lipids [monounsaturated fatty acids (MUFA)] to satu-
rated lipids [saturated fatty acids (SFA)]. The MD
score (MDS) was calculated by the sum of the values
assigned to the nine components of the MDS and
ranged from 0 (minimal adherence to the traditional
MD) to 9 (maximal adherence).
Assessment of fetal growth and PTD
Birthweight was extracted from the pediatricians’
records at birth. Gestational age was established by
obstetricians on the basis of the last menstrual period
and corrected by ultrasound measurement recorded in
the first trimester of pregnancy. PTD was defined as
any birth occurring before 37 weeks of gestation. FGR
was defined according to the statistical method
described by Ego et al.19 and was determined by
comparing actual birthweight with the expected
birthweight, predicted by a multiple linear regression
including known determinants of growth such as
age, weight and height of the mother, parity, gesta-
tional age and sex. This definition therefore takes into
account the constitutional characteristics of the mother
of the child. Newborns with a weight below the tenth
percentile of the predicted distribution were consid-
ered growth-restricted.
Statistical analysis
The outcome variables of interest were PTD and FGR
as categorical variables. The primary exposure of
interest was MD adherence during pregnancy meas-
ured by the MDS. The score was categorised into
three levels of adherence, as previously done by
Trichopoulou et al.20 and Chatzi et al.13: low adherence
(MDS ≤ 3), medium adherence (MDS = 4 or 5), high
adherence (MDS ≥ 6). Multiple logistic regressions
were used to analyse dichotomous birth outcomes.
Regression models included covariates that have an
established or potential association with outcome vari-
ables and MD adherence: maternal region of birth
(Guadeloupe/Martinique, other Caribbean islands,
Europe), marital status (married or in couple, single or
single living with own family), pre-pregnancy body
mass index (BMI; in kg/m2) (underweight or normal:
<25, overweight or obese: ≥25), maternal education
(low: <5, medium: 5–12, high: >12 years of education),
enrolment site (university hospital, local antenatal care
clinic, local hospital), average weekly weight gain
during pregnancy (in g/week) (<340, ≥340) and
smoking during pregnancy (yes, no). Gestational
weight gain (GWG) was computed as average weekly
weight gain to take into account varying gestational
week at measurement. Adherence to IOM recommen-
dations21 was assessed in three categories (low, normal
or high weight gain during pregnancy) according
to pre-pregnancy BMI. All analyses were further
adjusted for total energy intake during pregnancy,
categorised into tertiles (in kJ/day) (<9243, 9234–
12 410, >12 410). Effect modifications according to pre-
pregnancy BMI and infant sex were tested and
considered significant when Wald test P value < 0.20.
Medically indicated and spontaneous PTD were also
studied separately. Analyses were performed with Sta-
tistical Analysis Systems statistical software package
version 9.3 (SAS Institute, Cary, NC, USA).
Results
The identified diet was characterised by high intakes
of fruits and nuts (median 501 g/d), dairy products
(median 331 g/d), vegetables (median 283 g/d),
cereals (median 272 g/d) and fish (median 88 g/d)
(Table 1). The mean MDS was 4.9 (±1.6) (median: 5,
interquartile range: 4–6). Twenty per cent of the
women had low adherence to MD (MDS ≤ 3), 42%
medium adherence (4 ≤ MDS ≤ 5) and 37% high
adherence (MDS ≥ 6). Women with high MDS differed
from those with low MDS by higher intakes of fish
(×4), vegetables (×3) and legumes (×3), fruits and nuts
(×2). Overweight and obese women did not differ
from underweight/normal regarding any food group
intake.
Women included in the analysis had a mean age
(± standard deviation) of 31 (±7) years (Table 2). Most
of them were born in Guadeloupe or Martinique
(78.4%) and were enrolled at the University Hospital
(73.8%). Of the 728 women, only 399 (56.2%) were
living in couple. Sixty-eight per cent had a medium
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education level and 27.5% had a high education level.
Fifty-two per cent had a normal pre-pregnancy BMI,
6.9% were underweight, 22.4% were overweight and
18.7% were obese. Women born in other Caribbean
Islands had significantly lower adherence to MD, and
those enrolled at the University hospital had signifi-
cantly higher MDS.
The mean birthweight was 3095 (±508) g. Preterm
deliveries accounted for 14.7% of all births
(interquartile range: 37–40 weeks), and 52.8% of them
were spontaneous. FGR was diagnosed in 93 new-
borns (12.8%). Preterm (14%, 17%, 13%) and FGR
(11%, 12%, 14%) prevalence was similar amongst the
three categories of MDS.
Table 3 reports the associations between MD adher-
ence during pregnancy and PTD, stratified for pre-
pregnancy BMI and infant sex. A non-significant
decrease in the risk of PTD in association with MDS
was observed in the entire sample of women (adjusted
odds ratio (aOR) 0.9, 95% confidence interval (CI) 0.8,
1.0). Adherence to the MD during pregnancy was asso-
ciated with a statistically significant decrease in the
risk of PTD in overweight and obese women (aOR 0.7,
95% CI 0.6, 0.9) (P heterogeneity < 0.01) especially
among those with low or normal weight gain during
pregnancy (Supporting Information File S2). There
was no correlation between MDS score and GWG in
overweight and obese women. We also observed an
almost significant reduced risk of PTD among baby
girls (aOR 0.8, 95% CI 0.7, 1.0), but the effect heteroge-
neity was not significant (P heterogeneity = 0.21).
MD adherence was not significantly associated with
the risk of delivering an infant with FGR, but we
observed a significant interaction term (P heterogene-
ity = 0.03) and a non-significantly decreased risk of
FGR associated with MDS among underweight and
normal-weight women only (aOR 0.8, 95% CI 0.6, 1.0)
(Table 4). The same pattern was observed when analy-
sis was restricted to FGR among term births.
Sensitivity analyses confirm these findings, showing
a statistically significant decrease in the risk of PTD in
relation with MD adherence among overweight and
obese women when taking into account infants
without FGR exclusively, and identical estimates
among indicated preterm deliveries. However, the
association between MD adherence and the risk of
PTD was not found significant among spontaneous
preterm deliveries (probably due to a lower propor-
tion of overweight and obese women in this group)
(Supporting Information File S2).
Table 2. Mediterranean Diet Score according to maternal
sociodemographic and lifestyle characteristics, preterm delivery




Maternal place of birth 0.03
Guadeloupe/Martinique 571 78.4 5.0 1.6
Other Caribbean islands 72 9.9 4.5 1.5
Europe 85 11.7 4.9 1.6
Marital status 0.64
Single 176 24.8 5.0 1.5
Married or in couple 399 56.2 5.0 1.6
Living with own family 135 19.0 4.8 1.6
Maternal Education (years) 0.30
Low (<5) 36 5.0 4.6 1.8
Medium (5–12) 492 67.6 4.9 1.5
High (>12) 200 27.5 5.0 1.6
Enrolment site <0.01
University hospital 537 73.8 5.1 1.5
Local antenatal care clinic 126 17.3 4.7 1.7
Local hospital 65 8.9 4.5 1.6
Pre-pregnancy BMI (kg/m2) 0.56
Underweight 50 6.9 5.3 1.8
Normal 379 52.0 4.9 1.6
Overweight 163 22.4 5.1 1.5
Obese 136 18.7 4.9 1.5
Weight gain during pregnancy
(g/week)
0.18
<340 372 51.1 5.0 1.5




<9234 241 33.1 4.9 1.7
9234–12 410 239 32.8 5.0 1.5
>12 410 248 34.1 5.0 1.5
Smoking during pregnancy 0.60
No 689 94.6 4.9 1.6
Yes 39 5.4 5.1 1.3
Alcohol during pregnancy 0.13
No 706 97.0 5.0 1.5
Yes 22 3.0 4.4 1.6
Sex of the newborn 0.78
Male 370 50.8 5.0 1.6
Female 358 49.2 4.9 1.6
Preterm delivery 0.27
No 621 85.3 5.0 1.6
Yes 107 14.7 4.8 1.5
Fetal growth restriction 0.85
No 635 87.2 4.9 1.6
Yes 93 12.8 5.0 1.5
MDS, Mediterranean diet score; SD, standard deviation; BMI,
body mass index.
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Comments
This study shows a significant reduction in the risk of
PTD among pregnant overweight and obese women
who ate a Mediterranean-type diet during their
pregnancy.
Its potential beneficial effects on health, especially
its potential to reduce the risks of cancer and cardio-
vascular and chronic diseases, have made the MD a
topic of major interest today.22–24 Despite the common
characteristics of this dietary pattern (high consump-
tion of fruit, vegetables, legumes and grains, moderate







OR 95% CI P-valuea
Non stratified modelb 728 107 0.9 0.8, 1.1 0.9 0.8, 1.0
Model stratified for BMIc <0.01
Underweight/normal 429 56 1.1 0.9, 1.3 1.1 0.9, 1.3
Overweight/obesity 299 51 0.7 0.6, 0.9 0.7 0.6, 0.9
Model stratified for infant sexb 0.20
Male 370 58 1.0 0.8, 1.2 1.0 0.8, 1.2
Female 358 49 0.9 0.7, 1.0 0.8 0.7, 1.0
aP values for the effect heterogeneity test.
bAdjusted for maternal place of birth, marital status, pre-pregnancy BMI, maternal education, enrolment site, weight gain during
pregnancy, energy intake and maternal smoking during pregnancy (N = 710 with complete data).
cAdjusted for maternal place of birth, marital status, maternal education, enrolment site, weight gain during pregnancy, energy intake
and maternal smoking during pregnancy (N = 710 with complete data).
PTD, preterm delivery; OR, odds ratio; CI, confidence interval; BMI, pre-pregnancy body mass index.







OR 95% CI P-valuea
All births
Non stratified modelb 728 93 1.0 0.9, 1.2 1.0 0.8, 1.1
Model stratified for BMIc 0.03
Underweight/normal 429 42 0.9 0.7, 1.1 0.8 0.7, 1.0
Overweight/obesity 299 51 1.1 0.9, 1.4 1.2 0.9, 1.5
Model stratified for infant sexb 0.69
Male 370 39 1.0 0.8, 1.2 0.9 0.7, 1.1
Female 358 54 1.0 0.9, 1.2 1.0 0.8, 1.2
Among term births
Non-stratified modelb 621 68 1.0 0.9, 1.2 1.0 0.8, 1.2
Model stratified for BMIc 0.05
Underweight/normal 373 31 0.9 0.7, 1.2 0.8 0.7, 1.1
Overweight/obesity 248 37 1.2 0.9, 1.5 1.3 0.9, 1.7
Model stratified for infant sexb 0.92
Male 312 26 1.1 0.8, 1.4 0.9 0.7, 1.3
Female 309 42 1.0 0.8, 1.3 1.0 0.8, 1.2
aP values for the effect heterogeneity test.
bAdjusted for maternal place of birth, marital status, pre-pregnancy BMI, maternal education, enrolment site, weight gain during
pregnancy, energy intake and maternal smoking during pregnancy (N = 710 with complete data in all births, N = 609 in term births
only).
cAdjusted for maternal place of birth, marital status, education level, enrolment site, weight gain during pregnancy, energy intake and
maternal smoking during pregnancy (N = 710 with complete data in all births, N = 609 in term births only).
FGR, fetal growth restriction; OR, odds ratio; CI, confidence interval; BMI, body mass index.
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consumption of fish, dairy products and alcohol, low
meat intake), it is subject to some regional variations
associated with sociocultural, population and geo-
graphic differences,25,26 as well as with changes and
different influences associated with the globalisation
process.27 These factors make it difficult to establish a
specific definition. To these difficulties we must add
the nutritional specificities of pregnant women, who
should avoid alcohol consumption during pregnancy
because of its harmful impact on fetal development
and should consume more dairy products than usual
because of their increased calcium requirements.
Chatzi et al.13 showed heterogeneity between Spain
and Greece, countries traditionally known for an MD:
intake of fish and dairy products was higher in the
Atlantic region of Spain and fruit and nut intake
higher in Crete. They reported a lower risk of deliver-
ing FGR infants for women with high MD adherence
in the Mediterranean-INMA study (Spain), but not in
the Atlantic-INMA or the RHEA cohort (Greece). If
we compare these observations with the dietary
pattern of our Guadeloupian population, we observe
higher daily consumption of vegetables (283 g/day),
fruit and nuts (501 g/day) and fish (88 g/day) in this
cohort than among the women questioned in the
Atlantic Spain, Mediterranean Spain or Greek cohorts.
Although this dietary profile does not truly match any
of these three particular patterns, the high fruit and
nut intake and moderate dairy product consumption
are similar to that of the Greek cohort, while the high
fish consumption is closer to the pattern of the Atlan-
tic region of Spain.
Very few studies have examined the effect on length
of gestation and fetal growth of eating an MD during
pregnancy.9,10,12,13 To our knowledge, only a few recent
prospective studies have shown an association
between this type of diet and the risk of PTD. In 2005,
a randomised study in a cohort of Norwegian women
showed a 90% reduction in the PTD rate among
women who ate a low-cholesterol diet and reduced
their SFA intake during pregnancy.28 In that study, the
women in the intervention group were supposed to
follow a diet including greater intake of fish, vegeta-
ble oils (olive oil in particular), fruit and vegetables,
nuts, and a reduction in meat, butter, margarine,
cream and other fat-rich dairy products, together with
a reduction in coffee. Among the 141 women included
in the intervention group, 1 woman (0.7%) gave birth
to a preterm child, compared with 11 (7.4%) of the 149
women in the control group.
In an observational cohort of 35 530 Danish women
published in 2008, Mikkelsen et al.9 showed a 72%
reduction in the risk of early preterm delivery
(defined as birth before 35 weeks of gestation) associ-
ated with following an MD during pregnancy. The
women meeting all the following criteria were consid-
ered to be following an MD correctly: consumption of
fish at least twice a week, consumption of olive oil,
high consumption of fruit and vegetables (at least five
a day), meat eaten a maximum of twice a week and a
maximum of two cups of coffee a day.
Similarly, an MD throughout pregnancy appeared
to reduce the risk of PTD in our study. According to
Khoury et al.,28 several hypotheses may explain this
effect. Some factors included in this diet could con-
tribute to this result, in particular, the n-3 (omega-3)
polyunsaturated fatty acids (PUFA). Increased intake
of PUFA together with a reduction in SFA could influ-
ence the levels of inflammatory cytokines, which are
involved in the pathophysiological mechanisms of
PTD.29 Despite some contradictory findings, several
studies have shown an association between PUFA and
the duration of gestation.30 Khoury et al.28 also suggest
that some micronutrients, such as vitamins C and E,
influence this increased duration of gestation; they
also suggest that some dietary factors may play a role
in reducing intrauterine bleeding, which is a known
risk factor for PTD. Finally, according to Ness et al.,31
there is probably an interaction between maternal
blood levels of two folate isoforms and the risk of
preterm delivery.
A novel finding in this study is that the beneficial
effects of the MD on the risk of PTD were significantly
greater among overweight and obese women com-
pared with the normal and underweight women,
although MDS score did not differ between these two
categories. A pathophysiological perspective may
explain this result. Excess weight is known to increase
the risk of glucose intolerance and pregnancy-related
diabetes.32 Moreover, it is recognised that glucose
intolerance is associated with a shorter duration of
gestation, independently of other known risk factors
for PTD.33,34 An appropriate diet, including fewer
simple carbohydrates, should result in better blood
glucose regulation, which in turn should be associated
with an increase in the duration of gestation, espe-
cially for obese women, who might be the first to
benefit from this change. In our study, there is no indi-
cation that a mode of action of MD adherence through
a reduction in GWG in overweight/obese women is
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acting, since no correlation was observed between
MDS score and GWG.
Moreover, we observed a slight decreased risk of
FGR associated with MDS among underweight and
normal-weight women with a significant interaction
term. This result is in accordance with a previous
analysis within a large mother–child cohort in Spain
that have showed a significantly lower risk of deliver-
ing an FGR infant for weight among women with
high MD adherence.13
This study has numerous strengths. To our knowl-
edge, it is the first prospective cohort study to explore
the association between an MD in pregnant women
and fetal growth and PTD in a Caribbean population
of African descent. The few studies in this domain
have been conducted principally in European Nordic
or Mediterranean populations. The particularly high
rates of PTD and low birthweight in the Caribbean
population of African descent makes research into
factors that might reduce these risks a public health
priority. Data on food consumption come from an FFQ
specific to the French West Indies (in particular, in
terms of types of foods and methods of preparation
and cooking) and validated by various methods
described above. To minimise the response biases
inherent in this type of questionnaire, a trained inves-
tigator administered it during a face-to-face interview.
In our study, introducing an interviewer in the dietary
assessment was relevant since the women’s education
level was low or medium for 72.6% of them, and some
of them probably did not speak French fluently. FGR
was defined according to an internal reference in view
of the absence of reference curves adapted to this
population. Midwives and paediatricians participating
in this cohort study collected the fetal measurements
at birth.
This study is nonetheless subject to some limita-
tions. The PTD rate observed in our cohort of preg-
nant women in Guadeloupe is high (14.7%), exceeding
the estimates for the overseas districts and territories
obtained from the French Perinatal Survey conducted
in 2010 (12%).15 The high recruitment at the Guade-
loupe University Hospital (73.8%) probably explains
this difference since it favours inclusion of pregnant
women with diseases during pregnancy, indications
of induced delivery.
On the other hand, the FFQ was administered at the
end of pregnancy and concerned the women’s
average diet throughout pregnancy. We therefore
could not take into account the possible variations in
diet during pregnancy or define a window of expo-
sure during which the dietary pattern might be more
important. A longitudinal study intended to identify
dietary patterns among women throughout their
pregnancy nonetheless shows that these variations are
not significant.35 Finally, the intake estimates were
completed retrospectively, after delivery. Accordingly,
they could possibly have been influenced by the preg-
nancy outcome. This is nonetheless improbable
because women with major pregnancy-related dis-
eases were not included in the study; 99.1% of the
PTD were moderately preterm, and the detailed ques-
tionnaire did not refer to any ‘at risk’ food, except for
alcoholic beverages.
In conclusion, among women who were overweight
or obese before pregnancy, the risk of PTD was signifi-
cantly lower for those who followed an MD during
pregnancy. This result, if confirmed, suggests a benefit
of this type of diet during pregnancy and is especially
interesting in the French West Indian population,
which has a particularly elevated prevalence of obesity
and PTD. Indeed, the multi-causal and complex
nature of PTD makes its control particularly difficult.
As a potentially modifiable contributor to PTD risk,
setting up preventive dietary measures as part of the
management of these overweight and obese pregnan-
cies may have a substantial impact on the child’s
health status at birth and subsequent outcome.
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